Thyrocare Technologies Limited
Symbol: THYROCARE.BO
BSE
603.8
INRMarket price today
50.3318
P/E Ratio
0.9063
PEG Ratio
31.97B
MRK Cap
- 0.00%
DIV Yield
Thyrocare Technologies Limited (THYROCARE-BO) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1400.7 | 1388.4 | 1176.9 | |||||||||
balance-sheet.row.short-term-investments | 0 | 1223 | 1252.1 | 1044.9 | |||||||||
balance-sheet.row.net-receivables | 0 | 856.7 | 944.8 | 513.5 | |||||||||
balance-sheet.row.inventory | 0 | 276.7 | 245.3 | 233.6 | |||||||||
balance-sheet.row.other-current-assets | 0 | 53.2 | 112.8 | 28.4 | |||||||||
balance-sheet.row.total-current-assets | 0 | 2729.4 | 2700.2 | 2404.4 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1944.3 | 1867.9 | 1600.9 | |||||||||
balance-sheet.row.goodwill | 0 | 1002.8 | 1002.8 | 1002.8 | |||||||||
balance-sheet.row.intangible-assets | 0 | 7.9 | 8.3 | 9.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1010.7 | 1011.1 | 1012.5 | |||||||||
balance-sheet.row.long-term-investments | 0 | 223.1 | 243.8 | 270.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 122.7 | 64.9 | 56.3 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 297 | 188.7 | 113.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 3597.8 | 3376.4 | 3053.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.account-payables | 0 | 239.9 | 165.3 | 250.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 71.9 | 50 | 30.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 18.3 | 18.3 | 18.6 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 161.2 | 157 | 54.5 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 91.9 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 398.4 | 336.5 | 312.5 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 204 | 165.7 | 234.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.total-liab | 0 | 975 | 810.9 | 1185.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 529.3 | 529 | 528.7 | |||||||||
balance-sheet.row.retained-earnings | 0 | 3434.2 | 3568.8 | 2599.2 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1255.9 | 1244.1 | 1225.8 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 123.6 | -76.2 | -80.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5343 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.minority-interest | 0 | 9.2 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 5352.2 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 221 | 209.2 | 211 | |||||||||
balance-sheet.row.total-debt | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.net-debt | 0 | 55.4 | 70.7 | -47.1 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 874.1 | 2279 | 1525.4 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -247.4 | -731.2 | -522.2 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 211.7 | 23.2 | 16.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 57.9 | -792.2 | -176.5 | |||||||||||
cash-flows.row.account-receivables | 0 | -14.3 | -587.2 | -288.1 | |||||||||||
cash-flows.row.inventory | 0 | -31.4 | -11.7 | -27.4 | |||||||||||
cash-flows.row.account-payables | 0 | 74.2 | -84.8 | 31.5 | |||||||||||
cash-flows.row.other-working-capital | 0 | 29.4 | -108.5 | 107.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.7 | 16.6 | 1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 30.2 | 42.5 | 42.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -1919.9 | -1730 | -1361.1 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1932.5 | 1593.5 | 1042.1 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 3.8 | 236.6 | 56.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -389.9 | -235.7 | -486.6 | |||||||||||
cash-flows.row.debt-repayment | 0 | -55.3 | -53.8 | -25 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.3 | 0.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | -55.3 | -53.8 | -62.6 | |||||||||||
cash-flows.row.dividends-paid | 0 | -793.5 | -793.1 | -528.4 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 42 | 6.3 | -0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -861.8 | -894.1 | -615.8 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -2.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 41.4 | 4.3 | 44.9 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.7 | 136.3 | 132 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 136.3 | 132 | 87.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 1293.1 | 1134.1 | 1147.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 856.6 | 755.8 | 880.4 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 5266.7 | 5888.6 | 4946.2 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 1632.3 | 1696.9 | 1639 | |||||||||
income-statement-row.row.gross-profit | 0 | 3634.4 | 4191.7 | 3307.2 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.operating-expenses | 0 | 2788.2 | 2173.1 | 1895.9 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 4420.5 | 3870 | 3534.9 | |||||||||
income-statement-row.row.interest-income | 0 | 13.8 | 7.1 | 7.9 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 865.5 | 2044.2 | 1455.9 | |||||||||
income-statement-row.row.income-before-tax | 0 | 885.9 | 2277.2 | 1524.7 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 242.3 | 515.8 | 393.2 | |||||||||
income-statement-row.row.net-income | 0 | 643.6 | 1761.4 | 1131.5 |
Frequently Asked Question
What is Thyrocare Technologies Limited (THYROCARE.BO) total assets?
Thyrocare Technologies Limited (THYROCARE.BO) total assets is 6327200000.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.708.
What is company free cash flow?
The free cash flow is 16.845.
What is enterprise net profit margin?
The net profit margin is 0.118.
What is firm total revenue?
The total revenue is 0.151.
What is Thyrocare Technologies Limited (THYROCARE.BO) net profit (net income)?
The net profit (net income) is 643600000.000.
What is firm total debt?
The total debt is 233100000.000.
What is operating expences number?
The operating expences are 2788200000.000.
What is company cash figure?
Enretprise cash is 0.000.